Practice Point CME - Oncology Podcast: Episode 12 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies - Part 1
Description
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, and combination therapies. These podcast episodes address educational gaps in TNBC management, offering interactive cases, discussions on emerging treatments, and strategies to improve patient outcomes.
Launch Date: December 5, 2024
Release Date: December 5, 2024
Expiration Date: November 30, 2025
FACULTY
Aditya Bardia, MD, MPH, FASCO
Associate Professor, Medicine, Harvard Medical School
Attending Physician, Medical Oncology, Massachusetts General Hospital
Dana-Farber/Harvard Cancer Center, Boston, MA
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
The University of Chicago Medicine Chicago, IL
his podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
Episode: https://rss.com/podcasts/practice-point-communications-oncology-podcast/1854816
Podcast: https://rss.com/podcasts/practice-point-communications-oncology-podcast
United States
